Hierarchical Immunosuppression of Regional Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma (Q67806389)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1762790%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1762790%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Hierarchical Immunosuppression of Regional Lymph Nodes in Patients with Head and Neck Squamous Cell Carcinoma (English)

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

head and neck squamous cell carcinoma

18 November 2022

main subject

1 reference

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

18 November 2022

author name string

M. B. Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1762790

18 November 2022

A. Lichtenstein

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1762790

18 November 2022

R. A. Mickel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1762790

18 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1762790

18 November 2022

publication date

1 October 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1762790%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

http://journals.sagepub.com/doi/pdf/10.1177/019459989110500403

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Otolaryngology—Head and Neck Surgery

18 November 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1762790%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1762790%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1762790%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

517-527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1762790%20AND%20SRC:MED&resulttype=core&format=json

Delayed hypersensitivity reactions in patients with squamous cell cancer of the head and neck

17 September 2019

cites work

1

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Immunologic abnormalities in head and neck cancer.

18 November 2022

2

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Depressed natural killer cell activity in cervical lymph nodes containing focal metastatic squamous cell carcinoma

18 November 2022

4

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Natural cytotoxicity in draining lymph nodes of squamous cell cancer in the maxillofacial region

18 November 2022

5

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer

18 November 2022

6

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Immunology of head and neck cancers

18 November 2022

7

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer

18 November 2022

8

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

18 November 2022

10

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

18 November 2022

12

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

NIH conference. New approaches to the immunotherapy of cancer using interleukin-2.

18 November 2022

13

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

18 November 2022

15

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

First place--Resident Clinical Science Award 1990. Suppression of lymphokine-activated killer cell cytotoxicity by a soluble factor produced by squamous tumors of the head and neck

18 November 2022

18

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

The glomerular permeability determined by dextran clearance using Sephadex gel filtration

18 November 2022

19

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Miniaturization of the standard 51Cr release assay for long term follow-up of NK activity of individual mice

18 November 2022

21

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Up- and down-regulation of human lymphokine (IL-2)-activated killer cell induction by monocytes, depending on their functional state.

18 November 2022

24

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Macrophage-mediated suppression of natural killer cell activity in mice bearing Lewis lung carcinoma

18 November 2022

25

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Changes in the host natural killer cell population in mice during tumor development. 2. The mechanism of suppression of NK activity

18 November 2022

26

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Kinetic analysis of the inhibition of natural killer (NK) activity by multiple populations of tumor-activated suppressor cells

18 November 2022

27

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Excessive prostaglandin E2 production by suppressor monocytes in head and neck cancer patients

18 November 2022

28

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapy

18 November 2022

29

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

Lymphokine-activated killer-cell function of lymphocytes from peripheral blood, regional lymph nodes and tumor tissues of patients with oral cancer

18 November 2022

31

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer

18 November 2022

32

1 reference

https://api.crossref.org/works/10.1177/019459989110500403

18 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1762790%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference